A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 483 participants.
Also called NCT05445895
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 483 participants
- Sponsor
- Registry
-
NCT05445895
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05445895. Randomized; quadruple masking; primary purpose treatment. Start 2022-12-16 (actual); primary completion 2025-10-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Renexin CR 200/160mg
- Intervention (Drug)
- Plavix 75mg
- Lead sponsor
- SK Chemicals Co., Ltd.
Record details
- Record id
cardio:ct-nct05445895- Content hash
17102a1ea7e568109f54f37508c486ff6412ef01dc15a33bc790458b5cbe25bb